Ibenzmethyzin en es it fr

Ibenzmethyzin Brand names, Ibenzmethyzin Analogs

Ibenzmethyzin Brand Names Mixture

  • No information avaliable

Ibenzmethyzin Chemical_Formula

C12H19N3O

Ibenzmethyzin RX_link

http://www.rxlist.com/cgi/generic3/procarb.htm

Ibenzmethyzin fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=44

Ibenzmethyzin msds (material safety sheet)

Ibenzmethyzin MSDS

Ibenzmethyzin Synthesis Reference

No information avaliable

Ibenzmethyzin Molecular Weight

221.299 g/mol

Ibenzmethyzin Melting Point

223 oC

Ibenzmethyzin H2O Solubility

1420 mg/L

Ibenzmethyzin State

Solid

Ibenzmethyzin LogP

1.234

Ibenzmethyzin Dosage Forms

Capsule

Ibenzmethyzin Indication

For use with other anticancer drugs for the treatment of stage III and stage IV Hodgkin's disease.

Ibenzmethyzin Pharmacology

Procarbazine is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Procarbazine is cell-phase specific for the S phase of cell division.

Ibenzmethyzin Absorption

Procarbazine is rapidly and completely absorbed.

Ibenzmethyzin side effects and Toxicity

LD50=785 mg/kg (orally in rats)

Ibenzmethyzin Patient Information

Ibenzmethyzin Organisms Affected

Humans and other mammals